Further, the phosphate pre-prodrug of SN29176, termed SN35141, is refractory to AKR1C3 activation in vivo but retains promising efficacy in combination with radiotherapy in human tumour xenograft models. This evidence concerns the gene AKR1C3 and neoplasm.